Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura
- 15 December 1989
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 56 (6) , 667-675
- https://doi.org/10.1016/0049-3848(89)90284-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpuraEuropean Journal of Pediatrics, 1987
- Endoscopic Findings in Pediatric Patients with Henoch-Schonlein Purpura and Gastrointestinal SymptomsJournal of Pediatric Gastroenterology and Nutrition, 1987
- Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpuraKidney International, 1984
- A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtrationThrombosis Research, 1984
- Complement Activation in Renal DiseaseUremia Investigation, 1984
- Diagnostic and prognostic value of fibrin stabilising factor in Schonlein-Henoch syndrome.Archives of Disease in Childhood, 1983
- FACTOR XIII (FIBRIN STABILISING FACTOR) IN HENOCH‐SCHÖNLEIN'S PURPURAActa Paediatrica, 1977